Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting Conference (Transcript)

6/6/17

Merck & Co Inc. (NYSE:MRK)

Investor Briefing at 2017 ASCO Annual Meeting Call

June 5, 2017 18:45 ET

Executives

Teri Loxam - Investor Relations

Roger Perlmutter - President, Merck Research Labs

Frank Clyburn - President, Global Oncology

Analysts

Dave Risinger - Morgan Stanley

Jami Rubin - Goldman Sachs

Chris Schott - JPMorgan

Gregg Gilbert - DB

Alex Arfaei - BMO Capital Markets

Seamus Fernandez - Leerink Partners

Paul Choi - Barclays

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.